Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Omalizumab
(Xolair)		1件: Omalizumab1件: Omalizumab (Xolair) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
2Recombinant humanized monoclonal antibody omalizumab TO IGE
(Xolair)		1件: Omalizumab1件: Omalizumab (Xolair) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
3Rituximab combined with omalizumab
(Xolair)		1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
4Xolair1件: Omalizumab1件: Omalizumab (Xolair) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬2件: 46, 299 💬
5Xolair 150 MG pulver UND injektionslösung ZUR herstellung einer injektionslösung1件: Omalizumab1件: Omalizumab (Xolair) 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬